Advanced search
1 file | 4.97 MB

A nanobody‐based approach to amyloid diseases, the gelsolin case study

Adriaan Verhelle (UGent) and Jan Gettemans (UGent)
Author
Organization

Downloads

  • finaal book chapter.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 4.97 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Verhelle, Adriaan, and Jan Gettemans. 2016. “A Nanobody‐based Approach to Amyloid Diseases, the Gelsolin Case Study.” In Exploring New Findings on Amyloidosis, ed. Ana-Maria Fernandez-Escamilla, 313–335. Rijeka, Croatia: InTech.
APA
Verhelle, A., & Gettemans, J. (2016). A nanobody‐based approach to amyloid diseases, the gelsolin case study. In A.-M. Fernandez-Escamilla (Ed.), Exploring new findings on amyloidosis (pp. 313–335). Rijeka, Croatia: InTech.
Vancouver
1.
Verhelle A, Gettemans J. A nanobody‐based approach to amyloid diseases, the gelsolin case study. In: Fernandez-Escamilla A-M, editor. Exploring new findings on amyloidosis. Rijeka, Croatia: InTech; 2016. p. 313–35.
MLA
Verhelle, Adriaan, and Jan Gettemans. “A Nanobody‐based Approach to Amyloid Diseases, the Gelsolin Case Study.” Exploring New Findings on Amyloidosis. Ed. Ana-Maria Fernandez-Escamilla. Rijeka, Croatia: InTech, 2016. 313–335. Print.
@incollection{8509081,
  author       = {Verhelle, Adriaan and Gettemans, Jan},
  booktitle    = {Exploring new findings on amyloidosis},
  editor       = {Fernandez-Escamilla, Ana-Maria},
  isbn         = {9789535126188},
  language     = {eng},
  pages        = {313--335},
  publisher    = {InTech},
  title        = {A nanobody\unmatched{2010}based approach to amyloid diseases, the gelsolin case study},
  url          = {http://dx.doi.org/10.5772/63981},
  year         = {2016},
}

Altmetric
View in Altmetric